We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+8.66%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$19.6B
AUM Growth
+$2.1B
(+12%)
Cap. Flow
+$943M
Cap. Flow
% of AUM
4.81%
Top 10 Holdings %
Top 10 Hldgs %
14.75%
Holding
739
New
183
Increased
150
Reduced
140
Closed
230
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$314M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$235M |
| 3 |
lululemon athletica
LULU
|
+$221M |
| 4 |
Home Depot
HD
|
+$217M |
| 5 |
Analog Devices
ADI
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$263M |
| 2 |
TE Connectivity
TEL
|
+$242M |
| 3 |
Zoom
ZM
|
+$242M |
| 4 |
Qualcomm
QCOM
|
+$208M |
| 5 |
Meta Platforms (Facebook)
META
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.88% |
| 2 | Consumer Discretionary | 18.76% |
| 3 | Healthcare | 12.63% |
| 4 | Industrials | 12.54% |
| 5 | Financials | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NTST
401
NETSTREIT Corp
NTST
$2.03B
| $2.5M | 0.01% |
+151,286
| New | +$2.5M |
|
402
Elutia
ELUT
$36M
| $2.45M | 0.01% |
643,445
+551,468
| +600% | +$2.15M |
|
403
Solid Biosciences
SLDB
$918M
| $2.41M | 0.01% |
346,371
-100,000
| -22% | -$811K |
|
|
AMPS
404
DELISTED
Altus Power
AMPS
| $2.38M | 0.01% |
750,000
| – | – |
|
405
Core & Main
CNM
$8.67B
| $2.38M | 0.01% |
53,638
-373,043
| -87% | -$17.9M |
|
|
RWT
406
Redwood Trust
RWT
$574M
| $2.36M | 0.01% |
305,460
+105,460
| +53% | +$769K |
|
407
Acumen Pharmaceuticals
ABOS
$176M
| $2.33M | 0.01% |
939,603
| – | – |
|
408
Biohaven
BHVN
$2.19B
| $2.32M | 0.01% |
46,351
| – | – |
|
|
NOVA
409
DELISTED
Sunnova Energy
NOVA
| $2.31M | 0.01% |
+237,668
| New | +$2.1M |
|
|
SKX
410
DELISTED
Skechers
SKX
| $2.26M | 0.01% |
33,810
-857,249
| -96% | -$56.3M |
|
411
Achieve Life Sciences
ACHV
$685M
| $2.23M | 0.01% |
471,000
| – | – |
|
412
Alphatec Holdings
ATEC
$1.47B
| $2.22M | 0.01% |
398,846
-931,956
| -70% | -$7.15M |
|
413
Skye Bioscience
SKYE
$18.7M
| $2.17M | 0.01% |
554,177
+254,177
| +85% | +$1.43M |
|
414
GCM Grosvenor
GCMG
$834M
| $2.16M | 0.01% |
191,053
| – | – |
|
|
LAC
415
Lithium Americas
LAC
$1.18B
| $2.16M | 0.01% |
800,000
| – | – |
|
416
PSQ Holdings
PSQH
$14M
| $2.1M | 0.01% |
57,001
+10,000
| +21% | +$433K |
|
417
MDxHealth
MDXH
$23.3M
| $2.09M | 0.01% |
+1,007,000
| New | +$2.73M |
|
418
ASP Isotopes
ASPI
$540M
| $2.08M | 0.01% |
+747,022
| New | +$1.99M |
|
|
GPGI
419
GPGI Inc
GPGI
$4.16B
| $2.03M | 0.01% |
+174,705
| New | +$1.48M |
|
420
EyePoint Inc
EYPT
$1.13B
| $2.01M | 0.01% |
251,348
| – | – |
|
|
RNTX
421
Rein Therapeutics
RNTX
$67.9M
| $1.91M | 0.01% |
540,000
| – | – |
|
422
M&T Bank
MTB
$36.3B
| $1.86M | 0.01% |
+10,429
| New | +$1.73M |
|
|
BCAX
423
Bicara Therapeutics
BCAX
$1.82B
| $1.85M | 0.01% |
+72,807
| New | +$1.86M |
|
424
TORM
TRMD
$2.99B
| $1.82M | 0.01% |
+53,175
| New | +$1.95M |
|
425
ARS Pharmaceuticals
SPRY
$587M
| $1.81M | 0.01% |
+125,000
| New | +$1.49M |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q3 2024 Portfolio in Review
As of Q3 2024, Alyeska Investment Group held 739 positions worth $19.6B, up 12% from $17.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Alyeska Investment Group deployed $943M of net new capital in Q3 2024, opening 183 new positions and adding to 150 existing holdings. Its largest new stake was Microsoft: 734,107 shares worth $316M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Zoom, an estimated $242M trimmed.
- Alyeska Investment Group's largest Q3 2024 buy was Microsoft: 734,107 shares worth $316M.
- Alyeska Investment Group added most to lululemon athletica in Q3 2024, an estimated $221M increase.
- Alyeska Investment Group's biggest Q3 2024 reduction was Zoom, cutting an estimated $242M.
- Alyeska Investment Group fully exited Apple in Q3 2024, selling an estimated $263M.
- Alyeska Investment Group's ten largest holdings make up 15% of its $19.6B portfolio in Q3 2024.
- Alyeska Investment Group opened 183 new positions and closed 230 in Q3 2024.
- Alyeska Investment Group's portfolio value rose 12% quarter-over-quarter to $19.6B.
Based on Alyeska Investment Group's 13F filing for Q3 2024, filed 14 Nov 2024.